Tectonic Therapeutic, Inc. (TECX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
490 Arsenal Way
Watertown, MA 02472
United States of America (the)
Phone
+1 617 830 5233
Website
Sector
Healthcare
Industry
Biotechnology
Employees
60
First IPO Date
June 21, 2018
| Name | Title | Pay | Year Born |
| Alise S. Reicin | President, Chief Executive Officer, Secretary & Director | 1.03M | 1961 |
| Marcella K. Ruddy | Chief Medical Officer | 723,250 | 1963 |
| Daniel Lochner | Chief Financial Officer | 728,712 | 1983 |
| Marc Schwabish | Chief Business Officer | 0 | 1980 |
| John Diener | Senior Vice President of Antibody Engineering & Protein Sciences | 0 | N/A |
| Anthony Muslin | Chief Development Officer | 0 | N/A |
| Washington Alves | Senior Vice President of Technical Operations | 0 | N/A |
| Geraldine Peters-Wiles | Senior Vice President of Human Resources | 0 | N/A |
| Peter McNamara | Chief Scientific Officer | 0 | 1972 |
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator aimed at fibrosis, and various other GPCR modulators. Tectonic Therapeutic, Inc. is situated in Watertown, Massachusetts.